文献速递消化、代谢与肾脏急症心脑血管急症

倾向评分校正的观察性研究与匹配随机对照试验中VTE治疗后全因死亡率的比较:一项元流行病学研究

Comparison of All-Cause Mortality Following VTE Treatment Between Propensity Score-Adjusted Observational Studies and Matched Randomized Controlled Trials: Meta-Epidemiologic Study.
PubMed 文献 · Chest · 2018-10-25
一句话结论在7个VTE治疗问题上,倾向评分校正的观察性研究与匹配RCT的全因死亡率估计总体相似(汇总相对OR 0.89,95%CI 0.32-1.46),但个别问题效应方向或幅度可能不同。

该元流行病学研究系统检索PubMed和Web of Science,纳入倾向评分校正的观察性研究、RCT及RCT荟萃分析,评估VTE治疗后全因死亡率。通过标准化算法将观察性研究与至少一项RCT或RCT荟萃分析配对,共形成7个临床治疗问题的研究对。总体而言,观察性研究与RCT配对的死亡率估计无显著差异(汇总相对OR 0.89,95%CI 0.32-1.46;I2=23%)。但7个治疗问题中有2个(肺栓塞溶栓vs抗凝、VTE依诺肝素每日一次vs每日两次)效应方向显著不同,另2个(VTE利伐沙班vs维生素K拮抗剂、DVT家庭治疗vs住院治疗)效应幅度存在较大但非显著的差异。

要点

  • 总体而言,倾向评分校正的观察性研究与匹配RCT对VTE治疗后全因死亡率的估计无显著差异(汇总相对OR 0.89,95%CI 0.32-1.46;I2=23%)。
  • 7个治疗问题中,2个(肺栓塞溶栓vs抗凝、VTE依诺肝素每日一次vs每日两次)的效应方向在观察性研究与RCT之间显著不同。
  • 另2个问题(VTE利伐沙班vs维生素K拮抗剂、DVT家庭治疗vs住院治疗)的效应幅度在观察性研究与RCT之间存在较大但非显著的差异。
  • 作者结论认为,倾向评分校正的观察性研究与RCT在VTE治疗的全因死亡率上常表现相似,但效应方向或幅度偶尔可能出现差异。

适用人群与场景

  • 接受治疗的静脉血栓栓塞症(VTE)患者,涵盖肺栓塞和深静脉血栓形成。

研究设计与关键结果

  • 研究类型:元流行病学研究,系统检索PubMed和Web of Science,纳入倾向评分校正的观察性研究、RCT及RCT荟萃分析,评估VTE治疗后全因死亡率。
  • 共配对7个临床治疗问题的观察性研究与RCT或RCT荟萃分析。
  • 总体汇总相对OR为0.89(95%CI 0.32-1.46;I2=23%),观察性研究与RCT配对的死亡率估计无显著差异。
  • 7个治疗问题中,2个(肺栓塞溶栓vs抗凝;VTE依诺肝素每日一次vs每日两次)的效应方向显著不同。
  • 另2个问题(VTE利伐沙班vs维生素K拮抗剂;DVT家庭治疗vs住院治疗)的效应幅度存在较大但非显著的差异。

证据类型、等级与局限

  • 证据类型:元流行病学研究(系统比较观察性研究与RCT)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,倾向评分校正的观察性研究与RCT在VTE治疗的全因死亡率上常表现相似,但效应方向或幅度偶尔可能出现差异。

指南或共识出处

  • PROSPERO注册号CRD42018087819。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: It is unknown whether propensity score-adjusted observational studies produce results comparable to those of randomized controlled trials (RCTs) that address similar VTE treatment issues.

METHODS: The PubMed and Web of Science databases were systematically searched for propensity score-adjusted observational studies, RCTs, and meta-analyses of RCTs that estimated all-cause mortality following VTE treatment. After identifying distinct clinical treatment issues evaluated in the eligible observational studies, a standardized algorithm was used to identify and match at least one RCT or RCT meta-analysis publication for paired study design analyses. Meta-analyses were used to summarize groups of studies. Treatment efficacy statistics (relative ORs) were compared between the paired observational and RCT studies, and the summary relative ORs for all study design pairs were also calculated.

RESULTS: The observational and RCT study pairs assessed seven clinical treatment issues. Overall, the observational study-RCT pairs did not exhibit significantly different mortality estimates (summary relative OR, 0.89; 95% CI, 0.32-1.46; I2 = 23%). However, two of the seven treatment issue study pairs (thrombolysis vs anticoagulation for pulmonary embolism; once- vs twice-daily enoxaparin for VTE) exhibited a significantly different treatment effect direction, and there was a substantial (nonsignificant) difference in the magnitude of the effect in another two of the study pairs (rivaroxaban vs vitamin K antagonists for VTE; home treatment vs hospitalization for DVT).

CONCLUSIONS: This systematic comparison across seven VTE treatment topics suggests that propensity score-adjusted observational studies and RCTs often exhibit similar all-cause mortality, although differences in the direction or the magnitude of estimated treatment effects may occasionally occur.

TRIAL REGISTRY: PROSPERO; CRD42018087819; URL: http://www.crd.york.ac.uk/PROSPERO.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Coscia C, Jaureguizar A, Quezada CA, et al. Comparison of All-Cause Mortality Following VTE Treatment Between Propensity Score-Adjusted Observational Studies and Matched Randomized Controlled Trials: Meta-Epidemiologic Study. Chest. 2018. PMID: 30961834. doi:10.1016/j.chest.2018.10.016

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。